Shelton Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,000
Closed -$50K 787
2020
Q2
$50K Hold
10,000
﹤0.01% 656
2020
Q1
$34K Hold
10,000
﹤0.01% 632
2019
Q4
$55K Hold
10,000
﹤0.01% 823
2019
Q3
$57K Hold
10,000
﹤0.01% 814
2019
Q2
$77K Buy
10,000
+9,947
+18,768% +$53.6K ﹤0.01% 823
2019
Q1
$10K Sell
53
-9,947
-99% -$69K 0.04% 404
2018
Q4
$65K Hold
10,000
﹤0.01% 770
2018
Q3
$172K Hold
10,000
0.01% 884
2018
Q2
$139K Hold
10,000
0.01% 836
2018
Q1
$153K Hold
10,000
0.01% 813
2017
Q4
$115K Hold
10,000
0.01% 843
2017
Q3
$190K Hold
10,000
0.01% 803
2017
Q2
$241K Hold
10,000
0.02% 710
2017
Q1
$198K Sell
10,000
-90
-0.9% -$2.01K 0.01% 821
2016
Q4
$243K Hold
10,090
0.02% 733
2016
Q3
$280K Hold
10,090
0.02% 602
2016
Q2
$246K Hold
10,090
0.02% 630
2016
Q1
$339K Hold
10,090
0.03% 504
2015
Q4
$302K Buy
+10,090
New +$340K 0.03% 535

Other funds holding PGEN

Shelton Capital Management's PGEN Position: Q3 2020 in Review

Shelton Capital Management sold out of Precigen (PGEN) in Q3 2020, closing a stake of 10,000 shares — an estimated $50K sold.

Shelton Capital Management first reported a position in PGEN in Q4 2015 and held it in 19 quarters. The position peaked at $339K in Q1 2016. 159 funds tracked by Wall St. Rank hold PGEN as of Q3 2020.

  • Shelton Capital Management reported no remaining Precigen position as of Q3 2020 after selling out during the quarter.
  • Shelton Capital Management sold 10,000 Precigen shares in Q3 2020, an estimated $50K.
  • Shelton Capital Management first reported a position in Precigen in Q4 2015 and held it in 19 quarters.
  • Shelton Capital Management's Precigen position peaked at $339K in Q1 2016.
  • 159 funds tracked by Wall St. Rank held Precigen as of Q3 2020.

Based on Shelton Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.